Loading…
Academic Journal
ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AFTER CARDIOEMBOLIC STROKE: EVALUATION OF TREATMENT ADHERENCE IN REAL PRACTICE (Cohort study 'APOLLON')
I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov
Российский кардиологический журнал, Vol 0, Iss 7, Pp 105-110 (2017)
Saved in:
Title | ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AFTER CARDIOEMBOLIC STROKE: EVALUATION OF TREATMENT ADHERENCE IN REAL PRACTICE (Cohort study 'APOLLON') |
---|---|
Authors | I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov |
Publication Year |
2017
|
Source |
Российский кардиологический журнал, Vol 0, Iss 7, Pp 105-110 (2017)
|
Description |
Aim. To study the adherence to anticoagulation therapy of AF patients after CES, in real clinical practice.Material and methods. From 01.10.2013 to 31.03.2015 the data was analyzed, of 1291 patients after CES, and of those 661 fulfilled the inclusion/exclusion criteria (36,9% of males and 63,1% of females, mean age 68 y.o.). During the 12-month period of follow-up, 2 phone calls performed, in 180±5 days (V1) and 360±5 days (V2) from the stroke onset.Results. In 2014 only 6,9% of participants were taking anticoagulants, in 2015 — 17,5%. Only a half (n=330) of those knew of AF they had; 26,2% regarded AF as a risk factor life threatening and related to recurrent stroke; 15,4% refused to follow clinician prescriptions on anticoagulation. As the main medication, 65,3% patients noted acetylsalicylic acid, and only 7,9% — various anticoagulants. Annual mortality was 16,0%.Conclusion. In real clinical practice, AF patients after stroke have the same low awareness on anticoagulation necessity, as adherence, regardless of high annual mortality
|
Document Type |
article
|
Language |
Russian
|
Publisher Information |
«FIRMA «SILICEA» LLC, 2017.
|
Subject Terms | |